Effectiveness and safety of plasma convalescent therapy in patients with COVID-19
Not Applicable
- Conditions
- COVID-19 (SARS-CoV-2 infection)Infections and Infestations
- Registration Number
- ISRCTN16842454
- Lead Sponsor
- Ministry of Research and Technology/National Research and Innovation Agency (Kementerian Riset dan Teknologi Republik Indonesia)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
1. Confirmed COVID-19
2. Clinically moderate, severe, and/or critically ill
Exclusion Criteria
1. History of allergy to plasma
2. Patient with an estimated poor prognosis with sofa score >11, risk of mortality 53%
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mortality rate measured using a phone call to the family after 2 months follow up
- Secondary Outcome Measures
Name Time Method